European heart journal. Cardiovascular pharmacotherapy, 2021 (Journal Indexed in SCI)
Article / Article
Title of Journal :
European heart journal. Cardiovascular pharmacotherapy
Atrial fibrillation, Digoxin, Beta blocker, Rate control, Mortality, Hospitalizations, Quality of life, Permanent AF, Heart failure, CKD, EORP-AF, Registry, HEART-FAILURE, INCREASED MORTALITY, RISK, METAANALYSIS, GUIDELINES, MANAGEMENT, EFFICACY, STROKE
Aims The safety of digoxin therapy in atrial fibrillation (AF) remains ill-defined. We aimed to evaluate the effects of digoxin over beta-blocker therapy in AF.